Eturauhassyövät

Eturauhassyövät, also known as prostate cancer, is a common malignancy affecting men. It originates in the prostate gland, a small organ located below the bladder in males. The growth of prostate cancer is often slow, and many cases are diagnosed in their early stages when they are highly treatable. However, some forms can be aggressive and spread rapidly.

The exact causes of etaurauhassyövät are not fully understood, but several risk factors are known. Age is a significant factor, with the risk increasing as men get older. Family history of prostate cancer also increases an individual's susceptibility. Certain ethnic backgrounds, particularly African American men, have a higher incidence rate. Lifestyle factors such as diet and obesity are also being investigated as potential contributors.

Symptoms of etaurauhassyövät can vary. In early stages, there may be no noticeable signs. As the cancer progresses, symptoms can include difficulty urinating, a weak or interrupted urine flow, frequent urination especially at night, blood in the urine or semen, and pain or discomfort in the pelvic area. However, these symptoms can also be caused by non-cancerous conditions like benign prostatic hyperplasia (BPH).

Diagnosis typically involves a combination of a digital rectal exam (DRE) and a prostate-specific antigen (PSA) blood test. If these tests suggest a potential problem, a biopsy may be performed to confirm the presence and type of cancer. Treatment options depend on the stage and aggressiveness of the cancer, as well as the patient's overall health. They can include active surveillance, surgery, radiation therapy, hormone therapy, and chemotherapy. Regular screening is recommended for men, particularly those with increased risk factors, to facilitate early detection and improve outcomes.